【ニューデリー】Manmohan Singh首相(76)は先週土曜(24日)All-India Institute of Medical Sciences (AIIMS)付属病院において心臓のバイパス手術を受けた後、順調に回復しており、水曜(28日)までには集中治療室(ICU)から出られる見通しだ。（...続きを読む）
◆PM recovering fast after bypass surgery
【New Delhi】Prime Minister Manmohan Singh, who is recuperating at the All-India Institute of Medical Sciences (AIIMS) after a successful coronary bypass surgery on Saturday, will be taken out of the intensive care unit of AIIMS by Wednesday.
【Hyderabad】The Hyderabad-based API(Active Pharmaceutical Ingredients) and other essential drug discovery and development support services provider Neuland Laboratories Limited is foraying into peptides segment.
◆Clinical research business likely to face a slowdown
【New Delhi】Despite India is one of the most favoured destinations for conducting global clinical trials because of lower costs and easy availability of volunteers for human experiments, the growth in this business, which has growing at a robust pace over the past few years, is expected to decelerate to about 20% in 2009-10 from 35% in the current fiscal.
【Hyderabad】Hyderabad-based bio-pharmaceuticals company Shantha Biotechnics Limited, part of the France-based Merieux Allaince will be setting up a new modern vaccine manufacturing complex at Muppireddypally village in Ranga Reddy district of Andhra Pradesh.
【ハイデラバード】アンドラプラデシュ州Hyderabadを拠点にするインド初の生物医薬品メーカー、Biological E Ltd(BEL)は、ハイデラバード郊外ShameerpetのSP Biotech Park(Phase 2)に７５エーカーの生物医薬品およびワクチンの製造キャンパスを設けた。（...続きを読む）
◆Biological E inaugurates new facility in AP
【Hyderabad】Hyderabad-based Biological E Ltd, India's first private sector Biological Products Company, has set up a new 75-acre biopharmaceutical and vaccines manufacturing campus at SP Biotech Park (Phase 2) in Shameerpet, on the outskirts of Hyderabad.
【ハイデラバード】遺伝子組換え作物のトランスレーショナル・リサーチ・プラットフォーム(PTTC:Platform for Translational research on Transgenic Crops)をアンドラプラデシュ州Hyderabadの国際半乾燥地熱帯作物研究所(Icrisat:International Crops Research Institute for the Semi-Arid Tropics)キャンパスに設ける起工式がこのほど催された。（...続きを読む）
◆Icrisat, Govt launch project on transgenic crops
【Hyderabad】The foundation stone for Platform for Translational research on Transgenic Crops(PTTC) has been laid down recently at the International Crops Research Institute for the Semi-Arid Tropics (Icrisat) campus in Hyderabad.
【ムンバイ】目下、腫瘍／糖尿病／炎症性疾患／抗感染薬領域の研究を進めているPiramal Life Sciences Ltd(PLSL)は、２０１１年までに最初の新化学物質(NCE:New Chemical Entity)を市場に投入することを目指している。（...続きを読む）
◆Piramal Life aims to unveil its first new chemical entity by 2011
【Mumbai】Piramal Life Sciences is currently developing drugs in oncology, diabetes, inflammation disorders and anti-infectives and hoping to hit the market with its first New Chemical Entity (NCE) by 2011.
【チャンディガル】パンジャブ州Ludhianaを拠点に有機化学品や原末(bulk drug)の製造を手がけるIOL Chemicals and Pharmaceuticals (IOLCP)は２１６クロー(US$4431万)を投じ、各種製品の生産ラインを拡張する。これには最も広く用いられる医薬品イブプロフェン(ibuprofen)の生産ラインが含まれる。（...続きを読む）
◆IOL Chemicals to invest $44m in expansion
【Chandigarh】IOL Chemicals and Pharmaceuticals (IOLCP), the Ludhiana-based producers of organic chemicals and bulk drugs, will pump close to Rs 216 crore ($44.31m) in capacity expansion for its various product lines, including its most popular pharma product Ibuprofen.
【New Delhi】The government is planning to mobilise an investment of more than one billion dollars in the next five years for promoting innovation here through co-investing up to Rs 2,500 crore($484m) with a similar amount from private players for each innovating project.
【ハイデラバード】DuPont Crop Protection(DPCP)は、受託研究機関(CRO:contract research organisation)GVK Biosciences Private Ltdを、創薬化学研究サービス(Discovery Chemistry:化学と情報科学の両面からの新薬候補化合物の探索開発とリード探索およびリードの最適化サービス)のインドにおける戦略パートナーに指名、またBiocon Ltd傘下のSyngene International Private Limited(SIPL)をアライアンス・パートナーに指名した。（...続きを読む）
◆DuPont expands alliance with GVK and Biocon
【Hyderabad】DuPont Crop Protection has appointed GVK Biosciences, a contract research organisation, as a strategic partner for discovery Chemistry services in India and has signed up with Syngene International, a subsidiary of Biocon Ltd, as its alliance partner.
【チェンナイ】タミールナド州Chennai拠点の医療機器会社Trivitronは、英国企業Brandon Medical(BM)と、病院の手術室で用いるシャドーレス照明器具の製造を手がける合弁会社Brandon Trivitron Medical Technologies(BTMT)を設立した。（...続きを読む）
◆Trivitron sets up JV with Brandon Medical
【Chennai】Chennai-based medical technology company Trivitron has floated a joint venture, styled Brandon Trivitron Medical Technologies, with Brandon Medical of the UK to manufacture shadow-less lights used in operation theatres.
【金奈】位于泰米尔纳德州金奈的医疗技术企业 Trivitron与英国企业Brandon Medical设立联营公司Brandon Trivitron Medical Technologies。新公司将制造在医院手术室用的无影照明机具。
【ニューデリー】インド商工会議所連盟(FICCI:Federation of Indian Chambers of Commerce and Industry)が実施した業況見通し調査によると、大部分の業種が２００９－１０年の輸出成長率は無視できるほどか、マイナスに落ち込むと予想したが、製薬業だけは１６％の成長を見通した。（...続きを読む）
◆Pharma exporters forecast to grow 16% in 09-10
【New Delhi】A survey conducted by the Federation of Indian Chambers of Commerce and Industry (Ficci) revealed that most industrial sectors expected a negligible growth or contraction in exports during 2009-10. However pharmaceutical exporters forecasted a 16 per cent increase.
【Mumbai】Leading Indian drug makers such as Ranbaxy, Lupin, Zydus Cadila and Dishman, which forayed into Japan in the past three years, have already cornered about 10-15 per cent of the $3 billion generic market in Japan, which is estimated to grow manifold in the coming years due to health reforms.
◆Centre raises foodgrain, oilseeds output estimate for 2008-09
【New Delhi】The Agriculture Ministry has revised upwards its estimates of the country's foodgrains output for 2008-09 at 229.85 million tonnes (mt), against 227.88 mt in the earlier second Advance Estimates released in February.
【Hyderabad】Export of pharmaceutical goods grew by 10.2 per cent in February 2009 compared to year-ago period in dollar terms, according to data released by Pharmaceuticals Exports Promotion Council (Pharmexcil).
【Bangalore】The Indian biotechnology industry's overall turnover in 2008-09 was Rs 12,137 crore($2.58b), compared to Rs 10,273 crore($2.19) in 2007-08. The industry growth rate slipped to 18 per cent in 2008-09, compared with 30-34 per cent in the previous years.
【Mumbai】Keeping in view of the rising demand for its diclofenac transdermal patch 'NuPatch' in the overseas markets like the US, Zydus Cadila is setting up a new unit in its special economic zone (SEZ) near Ahmedabad.
【Chennai】Vegetable oils import continued to flood the country. For the current oil year that began in November, the imports till June totalled 58.24 lakh tonnes (lt) against 35.67 lt during the same period a year ago, a 63 per cent increase.
【ニューデリー】インド薬品監督総監(DCGI：Drug Controller General of India)オフィスは、民間の検査機関数社と、市場投入前の新薬を検査する施設を公共民間協力(PPP:public-private-partnership)方式で設ける交渉を進めている。（...続きを読む）
◆DCGI in talks with private labs to test new drugs
【New Delhi】Drug Controller General of India (DCGI) is in talks with some private labs to build infrastructure to test new drugs before launching them in the market through public-private-partnership (PPP) models.
【Mumbai】Oilmeal exports in July this year declined by 63 per cent to 173,329 tonnes as compared to 474,590 tonnes in the corresponding month last year with a gradual decline in overseas demand due to recessionary pressure coupled with the government's intended punitive action.
◆Pharma sector posts 11 per cent sales growth for Q 1
【New Delhi】The pharmaceutical sector post 11 per cent sales growth for the quarter ended June 2009, compared with the same period a year ago. However there is the wide divergence in performance within the sector.
【New Delhi】Indian pharmaceutical contract manufacturing industry is growing at thrice the rate of the global outsourcing market, and is expected to reach 2.3 billion dollars by the end of 2010 from 1.1 billion dollars in 2008.
【Mumbai】Oilmeal exports declined 50 per cent to 215,000 tonnes in August as compared to 427,000 tonnes in the same month last year.
【ニューデリー】国内の製薬会社は来月以降、インド薬品監督総監(DCGI：Drug Controller General of India)の輸出認可を取得することを義務づけられる。（...続きを読む）
◆Pharma cos to require DCGI nod for exports
【New Delhi】Domestic pharmaceutical companies will have to get the approval of central drug regulator Drug Controller General of India (DCGI) before exporting their medicines from next month, according to a health ministry official.
◆Four institutes shortlisted to develop Tamiflu material
【New Delhi】Four institutions have been identified by the Indian government for developing shikimic acid, the basic raw material used for making swine flu drug Tamiflu (Oseltamivir), currently being imported by drug manufacturers.
◆Natco to release 1 mn doses of swine flu drug by Oct end
【Hyderabad】Hyderabad-based drug maker Natco Pharma Limited announced that the company would be releasing into the market over 1 million doses (10 million tablets) of Natflu, its medicine for treatment of swine flu, by the end of next month.
【Chennai】Oilmeal exports in September increased 19 per cent to 2.31 lakh tonnes (lt) against 1.93 lt during the same period a year ago.
【ムンバイ】今年９月の植物油輸入量は９０万５０００トンと、昨年同月の６６万７０００トンに比べ３９％増加、包括輸入許可(open general licence)制度の下に、植物油の輸入が開始された１９９４年以来の最高をマークした。（...続きを読む）
◆Vegetable oil import in Sept rises 39%
【Mumbai】Vegetable oil imports in September rose 39 per cent to 9.05 lakh tonnes compared to 6.67 lt in the same period last year. It hit the highest figure for any month since these were allowed under an open general licence (OGL) in 1994.
【New Delhi】It appears that India's vegetable oil imports are going to rise by at least Rs 2,000 crore($434m) to Rs 27,000 crore($5.859bn) this year (November-October), as traders take advantage of a low-duty regime to pile up "cheaper" products from overseas.
【Hyderabad】Bangalore-based molecular diagnostic products company XCyton Diagnostics, which is in the process of developing two DNA macro chips for respiratory illness in the aged, and a multi-drug resistant disease, is scouting for partners that can help it market the products both domestically and globally.
【バンガロール】生物工学局(DOB:department of biotechnology)は、２００クロー(US$4340万)を投じ、カルナタカ州Bangaloreに、インド初の本格的な幹細胞研究所『inStem (The institute for Stem Cell Biology and Regenerative Medicine)』を設ける。（...続きを読む）
◆India's first stem cell institute to come up in Bangalore
【Bangalore】India's first major stem cell institute, called inStem (The institute for Stem Cell Biology and Regenerative Medicine), will be set up in Bangalore by the Department of Biotechnology (DBT), government of India at an investment of Rs 200 crore.
【New Delhi】A daily newspaper reported on Wednesday that Japan's largest drugmaker Takeda had begun to scout for opportunities in India, after Japan's second largest pharmaceutical company, Daiichi Sankyo Ltd, acquired Ranbaxy Laboratories in June last year.